ArticleNanomaterials (Basel, Switzerland)2026
PEDOT:PSS-Based OECT Common-Source Amplifiers for Electrophysiological Signal Amplification.
Article in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Stable amplification of weak electrophysiological signals is important for low-voltage bioelectronic interfaces, but the gain and waveform fidelity of organic electrochemical transistor (OECT)-based amplifiers are strongly influenced by device characteristics and bias conditions. Herein, we develop a poly(3,4-ethylenedioxythiophene):poly(styrenesulfonate) (PEDOT:PSS) vertical organic electrochemical transistor (vOECT) common-source amplifier using an integrated solid-state electrolyte and investigate its bias-dependent amplification behavior. The fabricated vOECTs exhibits typical p-type depletion-mode operation, effective gate-controlled current modulation, and a maximum transconductance of 22 mS. Transient measurements show reversible current switching with response time constants of 0.909 and 0.635 ms, while repeated gate-voltage modulation over approximately 1000 s confirms stable cycling behavior. Based on the measured transfer and output characteristics, a common-source amplifier model is constructed to analyze the relationship between gate bias, bias resistance, output swing, and voltage gain. By optimizing the voltage-divider bias network, the amplifier achieves a voltage gain of approximately 3.374. The optimized circuit amplifies sinusoidal signals from 1 to 100 Hz and simulated ECG, EEG, and EOG waveforms while preserving their main temporal features and producing the expected phase-inverted output. Distortion and frequency-response analyses further show a 1% total harmonic distortion point at an input peak amplitude of 113 mV and a -3 dB cut-off frequency of 625 Hz. These results demonstrate the importance of bias optimization for achieving stable low-frequency voltage amplification in PEDOT:PSS vOECT common-source amplifiers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.